Business & Consumer Services » Shell companies | Solanbridge Group Inc.

Solanbridge Group Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2010
2011
2012
2013
2014
Sales/Revenue
-
-
165.60
557.30
229.10
Cost of Goods Sold (COGS) incl. D&A
-
-
85.20
306.50
98.20
Gross Income
-
-
80.40
250.90
130.90
SG&A Expense
76.10
32.50
79.40
133.80
84.40
EBIT
76.10
32.50
2.30
71.70
19.20
Non Operating Income/Expense
-
-
-
-
12.50
Interest Expense
15.90
-
-
136.60
8.90
Pretax Income
92.00
32.50
2.30
64.90
2.10
Consolidated Net Income
92.00
32.50
2.30
64.90
2.10
Net Income
92.00
32.50
2.30
64.90
2.10
Net Income After Extraordinaries
92.00
32.50
2.30
64.90
2.10
Net Income Available to Common
92.00
32.50
2.30
64.90
2.10
EPS (Basic)
0.01
0.00
0.00
-
-
Basic Shares Outstanding
15,460.10
18,576.70
18,576.70
2,548,576.70
1,792,076.70
EPS (Diluted)
0.01
0.00
0.00
0.00
0.00
Diluted Shares Outstanding
15,460.10
18,576.70
18,576.70
2,548,576.70
1,792,076.70
EBITDA
76.10
32.50
2.30
71.70
-
Other Operating Expense
-
-
3.30
45.40
27.30

About Solanbridge Group

View Profile
Address
9595 Six Pines Drive
The Woodlands Texas 77380
United States
Employees -
Website http://www.solanbridgegroup.com
Updated 07/08/2019
Solanbridge Group Inc. is a development stage company, which operates as an investment and diversified holding company. It engages in production of medical marijuana by developing a commercial CBD-infused products in Nevada, California, and Colorado. Solanbridge Group was founded on October 12, 2000 and is headquartered in Houston, TX.